Multi-chaperone-peptide-rich mixture from colo-carcinoma cells elicits potent anticancer immunity

Cancer Epidemiol. 2010 Aug;34(4):494-500. doi: 10.1016/j.canep.2010.03.014. Epub 2010 May 6.

Abstract

Background: Chaperones play an important role in inducing anti-cancer immunity. To explore the probability of using chaperone-peptide-rich complexes extracted from colo-carcinoma cells as anti-cancer vaccine, we extracted and prepared chaperone-peptide-rich complexes from CT26 cells, which were subsequently investigated on anti-cancer efficacy.

Methods: The crude extracts of the CT26 cells treated with heat and Trichosanthin were precipitated with salt and dialyzed to remove proteins below 50kDa and above 300kDa in molecular weight; the proteins with the molecular weights in 70kDa, 90kDa, 95kDa, 110kDa and 170kDa were collected through gel filtration and SDS-PAGE. After confirmation, the purified proteins were used to determine their effects on lymphocyte proliferation, the activities of NK and CTL, tumor suppression and the tumor-bearing mouse survival.

Results: The majority of the chaperone-peptides of anti-cancer immunity in CT26 cells, including HSP70-antigen peptide, HSP90-antigen peptide, gp96-antigen peptide, HSP-110 antigen peptide, HSP170-antigen peptide, was satisfactorily extracted that the multi-chaperone-peptide-rich mixtures were obtained. All the mixtures prepared could elicit lymphocyte proliferation, enhance the activities of CTL and NK, reinforce the tumor suppression and prolong the mouse survival.

Conclusions: The multi-chaperone-peptide-rich mixtures could be prepared via dialysis and gel filtration combining with SDS-PAGE. Both the heat stress and Trichosanthin could induce and increase the mixtures, of which that treated by 42 degrees C heat and Trichosanthin was found to possess the strongest anti-cancer efficacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Blotting, Western
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Colonic Neoplasms / immunology
  • Colonic Neoplasms / therapy*
  • Heat Stress Disorders / immunology
  • Hot Temperature
  • Killer Cells, Natural / immunology
  • Lymphocyte Activation
  • Lymphoma / immunology
  • Lymphoma / therapy*
  • Mice
  • Mice, Inbred BALB C
  • Molecular Chaperones / immunology*
  • Peptide Fragments / immunology
  • Peptide Fragments / therapeutic use*
  • T-Lymphocytes, Cytotoxic / immunology*
  • Trichosanthin / pharmacology
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents, Phytogenic
  • Cancer Vaccines
  • Molecular Chaperones
  • Peptide Fragments
  • Trichosanthin